• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一氧化碳弥散能力作为系统性硬化症预后的预测指标

Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis.

作者信息

Peters-Golden M, Wise R A, Hochberg M C, Stevens M B, Wigley F M

出版信息

Am J Med. 1984 Dec;77(6):1027-34. doi: 10.1016/0002-9343(84)90183-9.

DOI:10.1016/0002-9343(84)90183-9
PMID:6507456
Abstract

In order to determine the predictive value of lung function studies for subsequent prognosis in systemic sclerosis, 71 patients with systemic sclerosis were followed up for a mean of five years after pulmonary function testing. A carbon monoxide diffusing capacity less than or equal to 40 percent of the predicted reference value was associated with only a 9 percent five-year cumulative survival rate compared with a 75 percent cumulative five-year survival in patients with a carbon monoxide diffusing capacity greater than 40 percent of predicted. An obstructive ventilatory defect was also associated with increased mortality, and all six patients with obstruction and a diffusing capacity less than 70 percent of the predicted died during the study period. Male gender, independent of abnormalities of pulmonary function, was also associated with a poor prognosis. Although it is not clear whether a severely impaired diffusing capacity is indicative of interstitial pulmonary fibrosis or pulmonary vasculopathy or is a marker of generalized vascular disease, a severely depressed carbon monoxide diffusing capacity is an important predictor of mortality in patients with systemic sclerosis.

摘要

为了确定肺功能研究对系统性硬化症后续预后的预测价值,对71例系统性硬化症患者在进行肺功能测试后平均随访了5年。一氧化碳弥散能力小于或等于预测参考值的40%时,5年累积生存率仅为9%,而一氧化碳弥散能力大于预测值40%的患者5年累积生存率为75%。阻塞性通气缺陷也与死亡率增加相关,在研究期间,所有6例有阻塞且弥散能力小于预测值70%的患者均死亡。男性,与肺功能异常无关,也与预后不良相关。虽然尚不清楚严重受损的弥散能力是间质性肺纤维化或肺血管病的指标,还是全身性血管疾病的标志,但一氧化碳弥散能力严重降低是系统性硬化症患者死亡率的重要预测指标。

相似文献

1
Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis.一氧化碳弥散能力作为系统性硬化症预后的预测指标
Am J Med. 1984 Dec;77(6):1027-34. doi: 10.1016/0002-9343(84)90183-9.
2
Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease.系统性硬化症伴间质性肺疾病患者运动诱导性低氧血症的预测因素。
Respir Care. 2014 Jan;59(1):75-80. doi: 10.4187/respcare.02452. Epub 2013 Jun 13.
3
Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis.系统性硬化症中肺部和肺外受累之间的相互关系。一项纵向分析。
Chest. 1994 Feb;105(2):489-95. doi: 10.1378/chest.105.2.489.
4
Isolated diffusing capacity reduction in systemic sclerosis.系统性硬化症中孤立性弥散功能降低
Arthritis Rheum. 1992 Jul;35(7):765-70. doi: 10.1002/art.1780350709.
5
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.系统性硬化症合并活动性肺泡炎患者呼吸困难程度与健康相关生活质量、功能能力及一氧化碳弥散能力的相关性:硬皮病肺部研究结果
Arthritis Rheum. 2005 Feb;52(2):592-600. doi: 10.1002/art.20787.
6
Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosis.不同一氧化碳弥散量(DLCO)测量指标在系统性硬化症中的比较。
Clin Rheumatol. 2013 Oct;32(10):1467-74. doi: 10.1007/s10067-013-2301-8. Epub 2013 Jun 4.
7
Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.特发性肺纤维化定量影像学与系统性硬化症的生理及临床特征的关系。
Ann Rheum Dis. 2016 Feb;75(2):374-81. doi: 10.1136/annrheumdis-2014-206076. Epub 2014 Dec 1.
8
Predictors of survival in systemic sclerosis (scleroderma).系统性硬化症(硬皮病)的生存预测因素。
Arthritis Rheum. 1991 Apr;34(4):403-13. doi: 10.1002/art.1780340405.
9
Pulmonary involvement in systemic sclerosis (scleroderma).系统性硬化症(硬皮病)中的肺部受累情况。
Arthritis Rheum. 1985 Jul;28(7):759-67. doi: 10.1002/art.1780280706.
10
Diffusing capacity for carbon monoxide as a predictor of gas exchange during exercise.一氧化碳弥散能力作为运动期间气体交换的预测指标。
N Engl J Med. 1987 May 21;316(21):1301-6. doi: 10.1056/NEJM198705213162103.

引用本文的文献

1
A 23-Plex Cytokine/Chemokine Analysis Identifies TNFRII, MMP-8, and sIL-1RII as Potential Biomarkers for Systemic Sclerosis.一项23种细胞因子/趋化因子分析确定肿瘤坏死因子受体II、基质金属蛋白酶-8和可溶性白细胞介素-1受体II为系统性硬化症的潜在生物标志物。
Biomedicines. 2025 Apr 16;13(4):967. doi: 10.3390/biomedicines13040967.
2
Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?系统性硬皮病患者孤立性 DLco/VA 降低:一种新的患者亚组?
Clin Rheumatol. 2018 Dec;37(12):3365-3371. doi: 10.1007/s10067-018-4342-5. Epub 2018 Oct 27.
3
An explanatory model of functional exercise capacity in patients with systemic sclerosis: considerations for rehabilitation programs.
系统性硬化症患者功能运动能力的解释模型:康复计划的考量因素
J Phys Ther Sci. 2016 Jan;28(2):569-75. doi: 10.1589/jpts.28.569. Epub 2016 Feb 29.
4
Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death.西班牙系统性硬化症网络登记处:生存率、预后因素及死亡原因
Medicine (Baltimore). 2015 Oct;94(43):e1728. doi: 10.1097/MD.0000000000001728.
5
Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients.估计右心室收缩压的变化可预测硬皮病患者队列的死亡率和肺动脉高压。
Ann Rheum Dis. 2013 Jul;72(7):1136-40. doi: 10.1136/annrheumdis-2012-201861. Epub 2012 Aug 11.
6
Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.从 REVEAL 研究中对结缔组织病相关肺动脉高压的特征分析:确定系统性硬化症为一种独特表型。
Chest. 2010 Dec;138(6):1383-94. doi: 10.1378/chest.10-0260. Epub 2010 May 27.
7
The current state of biomarkers in systemic sclerosis.系统性硬化症中的生物标志物现状。
Curr Rheumatol Rep. 2010 Feb;12(1):34-9. doi: 10.1007/s11926-009-0081-6.
8
Interpretation of pulmonary function test: issues and controversies.肺功能测试解读:问题与争议。
Clin Rev Allergy Immunol. 2009 Dec;37(3):173-80. doi: 10.1007/s12016-009-8123-4. Epub 2009 Mar 21.
9
HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities.高分辨率计算机断层扫描(HRCT)与硬皮病:肺损伤和功能异常的半定量评估
Radiol Med. 2009 Mar;114(2):190-203. doi: 10.1007/s11547-009-0367-9. Epub 2009 Mar 5.
10
Interstitial lung disease in systemic sclerosis.
Intern Emerg Med. 2007 Dec;2(4):250-5. doi: 10.1007/s11739-007-0075-1. Epub 2007 Dec 17.